UP Health System – Marquette, a Duke Lifepoint Hospital and Duke Health Affiliate, is pleased to announce it has acquired the latest innovation in robotic technology for minimally invasive lung biopsy. Robotic surgery allows providers to insert surgical instruments through one small incision, improving surgical outcomes by providing more reach, more stability, and more precision — allowing faster patient recovery.
This is made possible by a more than $600,000 investment from Lifepoint Health.
Lung cancer is the leading cause of cancer death in the US, accounting for about one in five of all cancer deaths. Each year, more people die of lung cancer than of colon, breast, and prostate cancers combined.
If your provider found a spot on your lung — commonly called a small mass or nodule — they may recommend you have it checked out further. While most lung nodules are benign, your provider may recommend a lung biopsy to confirm a diagnosis. Minimally invasive lung biopsy utilizes a robotic-assisted system that enables providers performing the procedure to reach all 18 segments of the lung.
During the biopsy, a tissue sample from the suspicious area is obtained and the cells are examined under a microscope to determine if cancer or another disease is present. In general, when a definitive diagnosis is obtained through a biopsy procedure, patients may avoid subsequent biopsies.
Comments